Kayne Anderson Rudnick Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.6M | Sell |
16,278
-1,137
| -7% | -$461K | 0.02% | 246 |
|
|
2025
Q1 | $8.67M | Sell |
17,415
-458
| -3% | -$228K | 0.02% | 245 |
|
|
2024
Q4 | $9.3M | Sell |
17,873
-1,014
| -5% | -$528K | 0.02% | 241 |
|
|
2024
Q3 | $11.7M | Sell |
18,887
-111
| -0.6% | -$68.7K | 0.03% | 228 |
|
|
2024
Q2 | $10.5M | Sell |
18,998
-3,291
| -15% | -$1.82M | 0.03% | 242 |
|
|
2024
Q1 | $13M | Sell |
22,289
-945
| -4% | -$549K | 0.03% | 235 |
|
|
2023
Q4 | $12.3M | Buy |
23,234
+243
| +1% | +$129K | 0.03% | 240 |
|
|
2023
Q3 | $11.6M | Sell |
22,991
-322
| -1% | -$163K | 0.03% | 241 |
|
|
2023
Q2 | $12.2M | Sell |
23,313
-16,486
| -41% | -$8.6M | 0.03% | 240 |
|
|
2023
Q1 | $22.9M | Buy |
39,799
+847
| +2% | +$488K | 0.07% | 176 |
|
|
2022
Q4 | $21.5M | Buy |
38,952
+2,298
| +6% | +$1.27M | 0.07% | 185 |
|
|
2022
Q3 | $18.6M | Buy |
36,654
+10,231
| +39% | +$5.19M | 0.06% | 188 |
|
|
2022
Q2 | $14.4M | Sell |
26,423
-51
| -0.2% | -$27.7K | 0.05% | 207 |
|
|
2022
Q1 | $15.6M | Buy |
26,474
+1,584
| +6% | +$936K | 0.04% | 212 |
|
|
2021
Q4 | $16.6M | Buy |
24,890
+262
| +1% | +$175K | 0.04% | 217 |
|
|
2021
Q3 | $14.1M | Buy |
24,628
+16,702
| +211% | +$9.54M | 0.03% | 216 |
|
|
2021
Q2 | $4M | Buy |
7,926
+363
| +5% | +$183K | 0.01% | 278 |
|
|
2021
Q1 | $3.45M | Buy |
7,563
+7,406
| +4,717% | +$3.38M | 0.01% | 276 |
|
|
2020
Q4 | $73K | Buy |
157
+119
| +313% | +$55.3K | ﹤0.01% | 424 |
|
|
2020
Q3 | $17K | Hold |
38
| – | – | ﹤0.01% | 454 |
|
|
2020
Q2 | $14K | Sell |
38
-8
| -17% | -$2.95K | ﹤0.01% | 434 |
|
|
2020
Q1 | $13K | Hold |
46
| – | – | ﹤0.01% | 433 |
|
|
2019
Q4 | $15K | Buy |
46
+38
| +475% | +$12.4K | ﹤0.01% | 414 |
|
|
2019
Q3 | $2K | Buy |
+8
| New | +$2K | ﹤0.01% | 523 |
|